On this page
MTHFR C677T (homozygous)
This genetic variation impacts the body's ability to convert folate into its active form, which is crucial for many bodily processes, including DNA synthesis and repair. While many individuals with this variant remain healthy, some research suggests potential associations with elevated homocysteine levels and certain health conditions.
Available at Jeen Health
Clinical tests that include this
Overview
MTHFR C677T (homozygous) describes the situation where an individual has inherited two copies of a particular change, or variant, in the MTHFR gene. This variant is known as C677T. The MTHFR gene provides instructions for making an enzyme called methylenetetrahydrofolate reductase. This enzyme is essential for processing folate (vitamin B9) in the body, converting it into a form that can be used for various biological reactions, including DNA synthesis and repairing [PMID:18384210].
Having two copies of the C677T variant means the MTHFR enzyme's activity is typically reduced compared to individuals without this variant. This can lead to a less efficient conversion of homocysteine into methionine, potentially causing higher levels of homocysteine in the blood. Although MTHFR C677T (homozygous) is relatively common, particularly in populations of Caucasian ancestry where it affects approximately 10-15% of people, many individuals with this genetic makeup do not experience health problems directly attributable to it [PMID:24784650].
Understanding the presence of this variant can be important in certain clinical contexts, particularly where folate metabolism or homocysteine levels are a concern. It is considered a genetic factor that may influence how the body handles folate and homocysteine, rather than a direct cause of disease in most cases.
Symptoms & clinical features
For most people, having homozygous MTHFR C677T does not lead to any noticeable symptoms or health problems. Many individuals live their entire lives without knowing they have this genetic variant. This is because the body often has compensatory mechanisms, or the reduction in enzyme activity is not severe enough to cause clinical issues.
However, in some instances, a reduced MTHFR enzyme activity associated with the C677T variant can lead to higher levels of homocysteine in the blood. Elevated homocysteine, known as hyperhomocysteinaemia, generally does not cause direct symptoms itself, but some research suggests it may be associated with an increased risk for certain health conditions over time [PMID:18384210].
In rare and more severe cases, often linked to other genetic or nutritional factors, very high homocysteine levels can contribute to more significant health concerns. These are typically assessed and managed by healthcare professionals. the presence of the MTHFR C677T homozygous variant alone is often not sufficient to cause severe health problems.
Video: Genetics 101
Affected organs
The MTHFR enzyme plays a fundamental role in metabolic processes that occur throughout the body, as folate is vital for many cellular functions. While not an organ-specific condition, issues arising from reduced MTHFR enzyme activity, such as elevated homocysteine, could theoretically have widespread effects.
Homocysteine is a molecule that is metabolised in the bloodstream. Persistent high levels of homocysteine may be associated with potential impacts on the cardiovascular system and the nervous system over a prolonged period. However, for most individuals with homozygous MTHFR C677T, these potential impacts do not translate into specific organ dysfunction, and clinical effects are rarely observed.
Risks & severity
The severity of health implications associated with MTHFR C677T (homozygous) varies widely. Many individuals with this variant experience no adverse health effects. The reduced enzyme activity is often considered a common genetic variation rather than a disease-causing mutation in isolation.
Some studies indicate a potential association between homozygous MTHFR C677T and moderately elevated homocysteine levels, especially if dietary folate intake is insufficient. Persistent high homocysteine levels have been a subject of research regarding potential links to cardiovascular disease and certain pregnancy complications, though the exact nature and strength of these links are complex and still being investigated. The overall risk to health from this variant alone is generally considered low for most people, and it does not typically lead to a severe clinical condition.
Genetic causes
MTHFR C677T (homozygous) is caused by inheriting two copies of a specific genetic variant within the MTHFR gene. The MTHFR gene is located on chromosome 1 and provides the genetic blueprint for making the methylenetetrahydrofolate reductase enzyme. This enzyme is crucial for a step in folate metabolism, specifically converting 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate.
This conversion is essential because 5-methyltetrahydrofolate is the active form of folate needed for the remethylation of homocysteine to methionine. Methionine is an amino acid vital for protein synthesis and other important biochemical pathways. The C677T variant involves a change at position 677 in the gene, where a cytosine (C) nucleotide is replaced by a thymine (T) nucleotide. This specific change leads to a different amino acid being incorporated into the MTHFR enzyme, which results in a thermolabile (heat-sensitive) enzyme with reduced activity [PMID:24784650].
When an individual is homozygous for the C677T variant, meaning they have inherited a T allele from both parents (TT genotype), the MTHFR enzyme's function is typically reduced by about 30-70% compared to individuals with two C alleles (CC genotype). This reduced function can affect the efficiency of homocysteine metabolism and potentially influence folate requirements [PMID:18384210].
- MTHFR methylenetetrahydrofolate reductaseThe MTHFR gene provides instructions for an enzyme essential in processing folate and amino acids, influencing key metabolic pathways related to health.
Inheritance pattern
MTHFR C677T (homozygous) follows an autosomal recessive pattern of inheritance. This means that an individual must inherit two copies of the C677T variant - one from each parent - to have the homozygous genotype (TT).
If a person inherits one copy of the C677T variant and one normal copy (CT genotype), they are considered heterozygous. Heterozygous individuals typically have moderately reduced MTHFR enzyme activity but rarely experience health concerns related to this variant. If both parents are carriers (heterozygous) for the C677T variant, there is a 25% chance with each pregnancy that their child will inherit two copies and be homozygous (TT), a 50% chance the child will be a carrier (CT), and a 25% chance the child will inherit two normal copies (CC).
When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.
Diagnosis & testing
Diagnosis of MTHFR C677T (homozygous) is made through genetic testing. This typically involves a blood or saliva sample from which DNA is extracted and analysed to identify the specific C677T variant in the MTHFR gene. This testing can determine if an individual has two copies of the variant (homozygous, TT), one copy (heterozygous, CT), or no copies (normal, CC).
Genetic testing for MTHFR variants is not routinely performed in the NHS, unless there is a specific clinical indication. Referral for genetic testing, if considered necessary, would typically come from a specialist clinician such as a clinical geneticist, haematologist, or obstetrician, often after reviewing an individual's personal or family medical history. In the UK, genetic tests for metabolic conditions like this may fall under specific NHS R-codes, if clinically indicated. Genetic counselling is often offered before and after testing to help individuals understand the implications of the results.
Management & lifestyle
For most individuals with MTHFR C677T (homozygous), no specific medical management is required, as they do not experience health problems. Management, if any, focuses on ensuring adequate folate intake and monitoring homocysteine levels when indicated by other clinical concerns.
Some healthcare professionals may suggest dietary modifications to ensure sufficient folate intake, such as consuming folate-rich foods (e.g., leafy green vegetables, citrus fruits, beans) or, in some cases, considering folic acid supplementation. The decision to supplement and the appropriate dosage should always be made in consultation with a healthcare professional, as excessive folic acid intake can have its own considerations. Lifestyle factors, such as a balanced diet and regular exercise, are generally recommended for overall health, irrespective of MTHFR status. Individualised advice can be provided through NHS care pathways, typically involving primary care doctors or specialists where relevant.
UK care pathway
In the UK, the identification of MTHFR C677T (homozygous) usually occurs through targeted genetic testing when a specific clinical concern prompts it. Referrals for such genetic testing typically originate from specialists within the NHS, such as clinical geneticists, neurologists, or specialists in obstetrics and gynaecology, following an assessment of an individual's health or family history. These tests align with the NHS Genomic Medicine Service (GMS) pathways. If genetic testing is performed, individuals will usually have access to a genetic counsellor who can explain the results and their implications for the individual and their family. The relevant genetic testing codes (R-codes) would be applied by the GMS depending on the clinical indication for testing.
Frequently asked questions
What does 'homozygous' mean for MTHFR C677T?
'Homozygous' means you have inherited two copies of the C677T variant in the MTHFR gene - one from your mother and one from your father. This is sometimes referred to as having the TT genotype.
Does MTHFR C677T (homozygous) always cause health problems?
No, most individuals with MTHFR C677T (homozygous) do not experience significant health problems. It is a common genetic variation, and the body often compensates for the reduced enzyme activity without clinical consequences.
How does MTHFR C677T affect folate?
The C677T variant reduces the activity of the MTHFR enzyme, which is responsible for converting folate into its active form. This can make the body less efficient at using certain types of folate.
Should I take folic acid supplements if I have MTHFR C677T (homozygous)?
Any decision about taking folic acid or other supplements should be made in consultation with a healthcare professional. They can assess your individual needs, diet, and any other health conditions to provide appropriate guidance.
Is MTHFR C677T (homozygous) common?
Yes, MTHFR C677T (homozygous) is relatively common, particularly in populations of Caucasian ancestry, affecting approximately 10-15% of individuals. Many people are unaware they have this genetic variant.
References
- Chatzidimitriou M, Chatzidimitriou D, Mavridou M. Thrombophilic gene polymorphisms and recurrent pregnancy loss in Greek women. International journal of laboratory hematology. 2017. PMID: 28603947
- Delli Carpini G, Giannella L, Di Giuseppe J. Homozygous C677T Methylenetetrahydrofolate Reductase (MTHFR) Polymorphism as a Risk Factor for Endometriosis: A Retrospective Case-Control Study. International journal of molecular sciences. 2023. PMID: 37895084
- Alfirevic Z, Mousa HA, Martlew V. Postnatal screening for thrombophilia in women with severe pregnancy complications. Obstetrics and gynecology. 2001. PMID: 11339929
- Teodoru CA, Munteanu M, Mercea N. Ophthalmic Vein Thrombosis Associated with Factor V Leiden and MTHFR Mutations. Diagnostics (Basel, Switzerland). 2023. PMID: 36980359
- Lin HY, Chung CY, Chang CS. Hyperhomocysteinemia, deep vein thrombosis and vitamin B12 deficiency in a metformin-treated diabetic patient. Journal of the Formosan Medical Association = Taiwan yi zhi. 2007. PMID: 17908667
- Paracchini V, Garte S, Taioli E. MTHFR C677T polymorphism, GSTM1 deletion and male infertility: a possible suggestion of a gene-gene interaction? Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals. 2006. PMID: 16484136
- Yang YL, Yang HL, Shiao SPK. Meta-Prediction of MTHFR Gene Polymorphisms and Air Pollution on the Risk of Hypertensive Disorders in Pregnancy Worldwide. International journal of environmental research and public health. 2018. PMID: 29438331
- Alfaleh A, Alkattan A, Mahmoud N. The Association Between MTHFR C677T Gene Polymorphism and Repeated Pregnancy Loss in Arabic Countries: a Systematic Review and Meta-Analysis. Reproductive sciences (Thousand Oaks, Calif.). 2023. PMID: 36854824